Gv 2017 Gp, L.l.c. - Net Worth and Insider Trading

Gv 2017 Gp, L.l.c. Net Worth

The estimated net worth of Gv 2017 Gp, L.l.c. is at least $67 Million dollars as of 2024-11-13. Gv 2017 Gp, L.l.c. is the of Verve Therapeutics Inc and owns about 10,368,489 shares of Verve Therapeutics Inc (VERV) stock worth over $67 Million. Details can be seen in Gv 2017 Gp, L.l.c.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gv 2017 Gp, L.l.c. has not made any transactions after 2022-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gv 2017 Gp, L.l.c.

To

Gv 2017 Gp, L.l.c. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gv 2017 Gp, L.l.c. owns 4 companies in total, including Arcus Biosciences Inc (RCUS) , GitLab Inc (GTLB) , and Decibel Therapeutics Inc (DBTX) among others .

Click here to see the complete history of Gv 2017 Gp, L.l.c.’s form 4 insider trades.

Insider Ownership Summary of Gv 2017 Gp, L.l.c.

Ticker Comapny Transaction Date Type of Owner
RCUS Arcus Biosciences Inc 2018-03-14 10 percent owner
GTLB GitLab Inc 2021-10-13 10 percent owner
DBTX Decibel Therapeutics Inc 2021-02-11 10 percent owner
LIMIT LIMIT 2022-11-04 10 percent owner

Gv 2017 Gp, L.l.c. Latest Holdings Summary

Gv 2017 Gp, L.l.c. currently owns a total of 1 stock. Gv 2017 Gp, L.l.c. owns 10,368,489 shares of Verve Therapeutics Inc (VERV) as of November 4, 2022, with a value of $67 Million.

Latest Holdings of Gv 2017 Gp, L.l.c.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VERV Verve Therapeutics Inc 2022-11-04 10,368,489 6.43 66,669,384

Holding Weightings of Gv 2017 Gp, L.l.c.


Gv 2017 Gp, L.l.c. Form 4 Trading Tracker

According to the SEC Form 4 filings, Gv 2017 Gp, L.l.c. has made a total of 3 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Verve Therapeutics Inc is the sale of 97,166 shares on November 4, 2022, which brought Gv 2017 Gp, L.l.c. around $3 Million.

Insider Trading History of Gv 2017 Gp, L.l.c.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gv 2017 Gp, L.l.c. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gv 2017 Gp, L.l.c. Ownership Network

Ownership Network List of Gv 2017 Gp, L.l.c.

No Data

Ownership Network Relation of Gv 2017 Gp, L.l.c.

Insider Network Chart

Gv 2017 Gp, L.l.c. Owned Company Details

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Gv 2017 Gp, L.l.c. is the 10 percent owner of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include Chief Accounting Officer Alexander Azoy , See Remarks Jennifer Jarrett , and director & 10 percent owner & President Juan C. Jaen .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Gv 2017 Gp, L.l.c. made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 196,515 shares made by Jennifer Jarrett , a net purchase of 16,248,095 shares made by Gilead Sciences Inc , and a net sale of 34,007 shares made by Juan C. Jaen .

In summary, during the past 3 months, insiders sold 0 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,214 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 16,009,881 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcus Biosciences Inc Insider Transactions

No Available Data

Gv 2017 Gp, L.l.c. Mailing Address

Above is the net worth, insider trading, and ownership report for Gv 2017 Gp, L.l.c.. You might contact Gv 2017 Gp, L.l.c. via mailing address: 1600 Amphitheatre Parkway, Mountain View Ca 94043.